agilon health (NYSE:AGL) Announces Quarterly Earnings Results

agilon health (NYSE:AGL) posted its quarterly earnings data on Tuesday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07), Zacks reports. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%.

agilon health Stock Up 1.8 %

AGL traded up $0.07 during trading hours on Tuesday, hitting $3.71. 6,725,137 shares of the company’s stock were exchanged, compared to its average volume of 5,298,555. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The firm has a market cap of $1.53 billion, a P/E ratio of -3.94 and a beta of 0.66. The firm has a 50 day moving average of $2.85 and a 200 day moving average of $3.05.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on AGL shares. Sanford C. Bernstein raised their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus dropped their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Royal Bank of Canada restated an “outperform” rating and set a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Finally, Needham & Company LLC initiated coverage on agilon health in a report on Friday, January 10th. They issued a “hold” rating on the stock. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $4.03.

Insiders Place Their Bets

In related news, Director Karen Mcloughlin purchased 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John William Wulf acquired 45,000 shares of the firm’s stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 77,500 shares of company stock worth $169,600 over the last 90 days. Corporate insiders own 3.20% of the company’s stock.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.